Pahul Hanjra

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Endothelial p130cas confers resistance to anti-angiogenesis therapy”.

Endothelial p130cas confers resistance to anti-angiogenesis therapy

Cell Reports(2022)10.1016/j.celrep.2022.110301

N/A

0DataRank · unranked

8 citations

Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M. Nick, Elaine Stur, Pahul Hanjra +10 more

EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer

International Journal of Molecular Sciences(2024)10.3390/ijms25021278

N/A

0DataRank · unranked

8 citations

Santosh K. Dasari, Sujanitha Umamaheswaran, Lingegowda S. Mangala, Emine Bayraktar, Cristian Rodriguez‐Aguayo +17 more

Epigenetic modulation of BARD1 to enhance anti-VEGF therapy

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102329

N/A

0DataRank · unranked

2 citations

Cristian Rodriguez-Aguayo, Elaine Stur, Sudhir Kumar, Lingegowda S. Mangala, Nicholas B. Jennings +24 more